Other researchers reported that luteoloside inhibited proliferation and modulated apoptosis by mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR) signaling pathways in human cervical cancer [13]. The gene discussed is MTOR; the disease is cervical carcinoma.